| Study | Country | Disease | Patient number | Mean age, year | Mode | Exercise program | Exercise duration (weeks) | INTERVAL | CONTINUOUS | INTERVAL | CONTINUOUS | INTERVAL | CONTINUOUS |
| Angadi et al., 2015 | US | CHF | 9 | 6 | 69 | 71.5 | TM | 3 d/wk, 4 × 4 mins @ 85%–90% of peak HR, 3 min recovery | 3 d/wk, 30 mins @ 70% of peak HR | 4 |
| Benda et al., 2015 | Netherlands | CHF | 10 | 10 | 63 | 64 | Cycling | 2 d/wk, 3.5 × 1 min @ 90%, of maximal workload, 10 periods | 2 d/wk, 30 min @ 60%–75% of maximal workload | 12 |
| Cardozo et al., 2015 | Brazil | CAD | 23 | 24 | 56 | 62 | TM | 3 d/wk, 2 mins @ 90% of peak HR 2 min recovery @ 60% peak HR | 3 d/wk, 30 mins @ 70%–75% of peak HR | 16 |
| Conraads et al., 2015 | Belgium | CAD | 85 | 89 | 57 | 59.9 | Cycling | 3 d/wk, 4 × 4 mins @ 90–95% of peak HR, 3 min recovery. 38 min total | 3 d/wk, 37 mins @ 70–75% of peak HR. 47 min total | 12 |
| Currie et al., 2013 | Canada | CAD | 11 | 11 | 62 | 68 | Cycling | 2 d/wk, 10 × 1 min @ 80%–104% PPO, 1 min recovery@10% PPO | 2 d/wk, 30–50 min @ 51%–65% PPO | 12 |
| Dimopoulos et al., 2006 | Greece | CHF | 10 | 14 | 59.2 | 61.5 | Cycling | 3 d/wk, 30 s@100% of WRp, 30 s rest, 40 min total | 3 d/wk, 40 mins @ 50% of WRp | 12 (36 sessions) |
| Freyssin et al., 2012 | France | CHF | 12 | 14 | 54 | 55 | Cycling | 5 d/wk, 12 × 30 s @ 50% (4 wks) + 80% (4 wks) of maximum power, 1 min recovery @ rest | 5 d/wk, 45 mins @ HRVT1 | 8 |
| Fu et al., 2013 | Taiwan | CHF | 14 | 13 | 67.5 | 66.3 | Cycling | 3 d/wk, 5 × 3 mins @ 80% of peak VO2 3 min recovery @ 40% peak VO2 | 3 d/wk, 60 mins @ 60% of peak VO2 | 12 |
| Iellamo et al., 2013 | Italy | CHF | 8 | 8 | 62.2 | 62.6 | TM | 2–5 d/wk, 2–4 × 4 mins @ 75%–80% of HHR 3 min recovery @ 45%–50% of HHR | 2–5 d/wk, 30–45 mins @ 45%–60% of HHR | 12 |
| Jaureguizar et al., 2016 | Spain | CAD | 36 | 36 | 58 | 58 | TM | (15–30) × 40 s @ the first (second) steep ramp test | 15–30 mins @ VT1 | 8 |
| Keteyian et al., 2014 | US | CAD | 15 | 13 | 60 | 58 | TM | 3 d/wk, 4 × 4 mins @ 80%–90% of HRR, 3 min recovery @ 60%–70% of HRR | 3 d/wk, 30 mins @ 60%–80% of HRR | 10 |
| Kim et al., 2015 | Republic of Korea | CAD | 14 | 14 | 57 | 60.2 | TM walking | 3 d/wk, 4 × 4 mins @ 85%–95% of HRR, 3 min recovery @ 450%–70% of HRR. 5 min total | 3 d/wk, 25 mins @ 70%–85% of HRR. 45 min total | 6 |
| Koufaki et al., 2014 | UK | CHF | 9 | 8 | 59.8 | 59.7 | Cycling | 3 d/wk, 2 × 10 min @ 100% of PPO, 5 min recovery @ 20%–30% of PPO | 3 d/wk, 1–4 months: 3 × (7–10) mins; 5-6 months: 40 mins; @ 40%–60% of peak VO2 | 24 |
| Madssen et al., 2014 | Norway | CAD | 15 | 21 | 55.5 | 60.5 | TM | 3 d/wk, 34 × 4 mins @ 85%–95% of peak HR, 3 min recovery @ 70% of peak HR | 3 d/wk, 46 mins @ 70% of peak HR | 12 |
| Moholdt et al., 2009 | Norway | CAD | 28 | 31 | 60.2 | 62 | TM | 5 d/wk, 4 × 4 mins @ 90% of peak HR, 3 min recovery @ 70% peak HR, 40 min total | 5 d/wk, 46 mins @ 70% of peak HR | 4 |
| Rocco et al., Prado et al., | Brazil | CAD | 17 | 20 | 56.5 | 62.5 | TM | 3 d/wk, 7 × 3 mins @ RCP, 7 × 3 min @ VAT. 42 min total | 3 d/wk, 50 mins @ VAT | 12 |
| Roditis et al., 2007 | Greece | CHF | 11 | 10 | 63 | 61 | Cycling | 3 d/wk, 30 × 30 s @ 100% of WRp, 40 min total | 3 d/wk, 40 mins @ 50% of WRp | 12 (36 sessions) |
| Rognmo et al., Amundsen et al., | Norway | CAD | 8 | 9 | 62.9 | 61.2 | TM walking | 3 d/wk, 4 × 4 mins @ 85%–95% of peak HR, 3 min recovery. 33 min total | 3 d/wk, 41 mins @ 50%–60% of peak VO2 | 10 |
| Ulbrich et al., 2016 | Brazil | CHF | 12 | 10 | 53.1 | 54 | TM | 3 d/wk, (4–6) × 3 mins @ 95% of peak HR, 3 min recovery @ 70% peak HR. 60 min total | 3 d/wk, 30 mins @ 75% of peak HR. 60 min total | 12 |
| Warburton et al., 2005 | Canada | CAD | 7 | 7 | 55 | 57 | TM | 2 d/wk, 2 mins @ 90% of VO2 reserve, 2 min recovery. 30 min total | 2 d/wk, 30 mins @ 65% of VO2 reserve | 16 |
| Wisløff et al., 2007 | Norway | CHF | 9 | 9 | 76.5 | 74.4 | TM | 3 d/wk, 4 mins @ 90%–95% of peak HR, 3 min recovery @ 50%–70% peak HR. 38 min total | 3 d/wk, 47 mins @ 70%–75% of peak HR | 12 |
|
|